MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC.
Quan J, Pan X, Li Y, Hu Y, Tao L, Li Z, Zhao L, Wang J, Li H, Lai Y, Zhou L, Lin C, Gui Y, Ye J, Zhang F, Lai Y.
Quan J, et al. Among authors: gui y.
Biomed Pharmacother. 2019 Feb;110:656-666. doi: 10.1016/j.biopha.2018.11.065. Epub 2018 Dec 12.
Biomed Pharmacother. 2019.
PMID: 30551118
Free article.
Retracted.